Lyme Disease Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033

Pages: 41 Published: December 27, 2022 Report Code: GDME702MM

Lyme Disease Tests Market Report Overview

The Lyme Disease Tests market size was valued at $10.3 million in 2022. Lyme disease is an inflammatory disease caused by a bacterium and is transmitted through the bite of infected ticks of the genus Ixodes. The Lyme Disease Tests market research report is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. It discusses in detail the impact of COVID-19 on the Lyme Disease Tests market for the year 2020 and beyond.

Lyme Disease Tests Market Outlook, 2022-2033 ($ Million)

Lyme Disease Tests Market Outlook, 2022-2033 ($ Million)

For more insights into the Lyme Disease Tests market forecast, download a free report sample

Lyme Disease Tests Market Dynamics

Lyme disease is a tick-borne disease. The Centers for Disease Control and Prevention (CDC) recommends antibiotics in the early stages of B. burgdorferi infection. Patients with certain neurological or cardiac manifestations may be given IV treatment with antibiotics. Lyme disease testing is done through a two-tiered serologic testing algorithm. The market for Lyme disease Tests will grow in the upcoming years across all regions, with the strongest growth being observed in the North America and Europe. The rise in Lyme disease diagnosis incidences are predicted to lead to a higher number of tests performed, as well as improved disease awareness and continuation of strong screening initiatives.

Lyme Disease Tests Market by Segments

The key segments in the Lyme Disease Tests market are Lyme Disease Enzyme Immunoassay Tests, Lyme Disease Other Tests, and Lyme Disease Western Blot Tests. Lyme Disease Enzyme Immunoassay Tests led the market in 2022.

Lyme Disease Tests Market Analysis by Segments, 2022 (%)  

Lyme Disease Tests Market Analysis by Segments, 2022 (%)

For more segment insights into the Lyme Disease Tests market, download a free report sample

Lyme Disease Tests Market Segmentation by Regions

The key regions in the Lyme Disease Tests market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. Lyme disease is one of the most common vector-borne diseases in North America. Despite it being a very common illness in the US, its diagnosis and treatment can be difficult for clinicians because of its diverse manifestations and the limitations of the currently available serological (blood) tests. Suburbanization is one of the major reasons that has contributed to a higher incidence of tick-borne diseases as humans encroach on wildlife.

Lyme Disease Tests Market - Competitive Landscape

Some of the leading companies in the Lyme Disease Tests market are Thermo Fisher Scientific Inc, PerkinElmer Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Qiagen NV, Meridian Bioscience Inc, Trinity Biotech Plc, DiaSorin SpA, Quidelortho Corp, and ERBA Diagnostics Inc. PerkinElmer Inc dominated the market in 2022.

Lyme Disease Tests Market Analysis by Companies, 2022 (%)

Lyme Disease Tests Market Analysis by Companies, 2022 (%)

To know more about the leading companies in the Lyme Disease Tests market, download a free report sample

Lyme Disease Tests Market Report Overview

Market Size (2022) $10.3 million
Forecast period 2022-2033
Historical Period 2015-2021
Key Regions North America, Europe, Asia Pacific, South America, and The Middle East and Africa
Key Segments Lyme Disease Enzyme Immunoassay Tests, Lyme Disease Other Tests, and Lyme Disease Western Blot Tests
Leading Companies Thermo Fisher Scientific Inc, PerkinElmer Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Qiagen NV, Meridian Bioscience Inc, Trinity Biotech Plc, DiaSorin SpA, Quidelortho Corp, and ERBA Diagnostics Inc

Segments Covered in the Report

Lyme Disease Tests Segments Outlook (Value, US$ Million, 2015-2033)

  • Lyme Disease Enzyme Immunoassay Tests
  • Lyme Disease Other Tests
  • Lyme Disease Western Blot Tests

Lyme Disease Tests Regional Outlook (Value, US$ Million, 2015-2033)

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East and Africa

Scope

This report provides:

  • Currently marketed Lyme disease tests and evolving competitive landscape.
  • Insightful review of the key industry trends.
  • Annualized total Lyme disease tests market revenue by segment and market outlooks from 2015-2030.
  • Market-level data on units, average selling prices, and market values.
  • Global, regional, and country-level market-specific insights.
  • Qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for Lyme disease tests market.
  • Competitive dynamics insights and trends provided for the Lyme disease tests market.
  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific MedTech regulatory landscape.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Lyme Disease tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Lyme Disease tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Lyme Disease tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Lyme Disease tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

Thermo Fisher Scientific Inc
PerkinElmer Inc
bioMerieux SA
Bio-Rad Laboratories Inc
Qiagen NV
Meridian Bioscience Inc
Trinity Biotech Plc
DiaSorin SpA
Quidelortho Corp
ERBA Diagnostics Inc
ZEUS Scientific Inc
Viramed Biotech AG

Frequently Asked Questions

The Lyme Disease Tests market size was $10.3 million in 2022.

The key regions in the Lyme Disease Tests market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa.

The key segments in the Lyme Disease Tests market are Lyme Disease Enzyme Immunoassay Tests, Lyme Disease Other Tests, and Lyme Disease Western Blot Tests.

Some of the leading companies in the Lyme Disease Tests market are Thermo Fisher Scientific Inc, PerkinElmer Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Qiagen NV, Meridian Bioscience Inc, Trinity Biotech Plc, DiaSorin SpA, Quidelortho Corp, and ERBA Diagnostics Inc.

$7,500

Can be used by individual purchaser only

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

Still undecided about purchasing this report?

Enquire Before Buying

Request a Free Sample

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods